Jean EngelaFounder

Germany -

Experienced professional with multi-disciplinary expertise in business development, consulting and biopharmaceutical development.

International experience gained in the multi-national pharmaceutical setting which includes 6 of the top 20 global pharmaceutical companies and biotech companies located in the UK, the Netherlands, Germany, Switzerland, Israel and South Africa.

Variety of roles including technical scientific positions, business development, project leadership and people management.

Experience in the development of a broad range of biopharmaceuticals:
- Recombinant proteins and monoclonal antibodies
- Vaccines including influenza and HIV (recombinant adenovirus)
- Advanced therapies (recombinant adeno-associated virus)

Subject matter expert in biopharmaceutical analytical development and validation, and extraneous agent safety.


Specialties: CMC; Biopharmaceutical Development; Biopharmaceutical Analytical Development; Process Development; Virus Safety; Virus Removal; Virus Validation.